与 «LYSOSOMAL»相关的英语书籍
在以下的参考文献中发现
lysosomal的用法。与
lysosomal相关的书籍以及同一来源的简短摘要提供其在 英语文献中的使用情境。
1
Lysosomal Storage Disorders: Principles and Practice
This book presents an overview of lysosomal storage disorders, and provides the reader with an understanding of clinical features, associated complications, and diagnosis and management approaches.
Gregory M. Pastores, 2010
2
Lysosomal Storage Disorders
Disease specific chapters provide thorough reviews of the clinical features of lysosomal storage disorders, their molecular basis and the commercial or experimental therapeutic approaches sought in this area.
John A. Barranger, Mario Cabrera-Salazar, 2007
3
Lysosomal Storage Disorders: A Practical Guide
Awareness of lysomal storage disorders needs to be raised and there is very substantial pharmaceutical interest to do so. The disorders are often viewed as obscurities but in fact they are treatable.
Atul Mehta, Bryan Winchester, 2012
4
Lysosomal Disorders of the Brain: Recent Advances in ...
Details recent advances in the molecular and cellular pathologies of a variety of lysosomal storage diseases. Also discusses the development of effective therapies.
Frances M. Platt, Steven U. Walkley, 2004
5
Nervous System
Lysosomal Storage Diseases—Advances in ...
Nervous System Lysosomal Storage Diseases—Advances in Research and Treatment: 2012 Edition is a ScholarlyPaper™ that delivers timely, authoritative, and intensively focused information about Nervous System Lysosomal Storage Diseas in a ...
6
Molecular Basis of
Lysosomal Storage Disorders
Molecular Basis of Lysosomal Storage Disorders
7
P38 MAPKs Coordinately Regulate Distinct Phases of Autophagy ...
p38 mitogen-activated protein kinases (MAPKs) control the endocytic trafficking of various growth-related cell surface receptors and transporters.
Shankar Varadarajan, 2008
8
Selective Enhancement of
Lysosomal Responses Clears ...
Protein deposition is a characteristic of Alzheimer's disease (AD) in which pathogenic accumulations of paired helical filaments (PHFs) and amyloid-beta peptides (e.g.
9
Pathophysiology of
Lysosomal Transport
The book also examines the transfer of macromolecules into the lysosomes, describes the analogy between mammalian lysosomes and vacuoles of plants and fungi, and reviews non-mediated transport.
10
Unrestrained Molecular Dynamics Simulations of Human ...
Molecular dynamics (MD) simulations have been performed at the atomic level to study autoproteolysis in human glycosylasparaginase (GA) precursor and the Finnish mutation AGUFIN.
William Michael York, 2007
包含词语«LYSOSOMAL»的新条目
找出国内和国际出版社所讨论的内容，以及词语
lysosomal在以下新条目的上下文中是如何使用的。
Visualizing lipid-formulated siRNA release from endosomes and …
By contrast, the late endosomal (Rab9) and lysosomal (LAMP1) markers were just being recruited or completely absent, respectively, at the time of release (Fig. «Nature.com, 七月 15»
First - BioMed Central
... cholesteanol, lysosomal enzymes, quantitative assessment of amino acids) [14], and genetic testing for SCA1,2,3,6,7 was performed. All results were normal. «BMC Blogs Network, 七月 15»
Listening to Yellen Cost You 80%
Alexion Pharmaceuticals, for instance, has an upcoming FDA decision on September 8 for Kanuma, its treatment of lysosomal acid lipase ... «Motley Fool, 七月 15»
Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) Sees Large …
... as pharmacological chaperones for treating a range of diseases, including lysosomal storage diseases and diseases of neurodegeneration. «Insider Trading Report, 七月 15»
"Saving Eliza" campaign helps another child
Sanfilippo is a lysosomal storage disease, described in my first post about Eliza. Mutations in any of four genes cause it. Will, with type B, is 1 in ... «Medical Xpress, 七月 15»
Amicus Therapeutics Given Consensus Recommendation of "Buy …
... of next-generation medicines for a range of rare and orphan diseases, with a focus on improved therapies for lysosomal storage disorders. «Dakota Financial News, 七月 15»
“Saving Eliza” Campaign Helps Another Child
Sanfilippo is a lysosomal storage disease, described in my first post about Eliza. Mutations in any of four genes cause it. Will, with type B, is 1 in ... «PLoS Blogs, 七月 15»
Dr. Charles W. Richard Joins uniQure as Senior Vice President to …
... a biotechnology company focused on developing second-generation enzyme replacement therapies for rare lysosomal storage diseases, ... «Nasdaq, 七月 15»
Pre-Market News Report on: BioMarin Pharmaceutical (NASDAQ …
Its commercial products comprise Vimizim, an enzyme replacement therapy for the treatment of MPS IV A, a lysosomal storage disorder; Naglazyme, ... «wsnewspublishers, 七月 15»
Parkinson's Disease: The Devil Is in the Protein
This past February, Lysosomal Therapeutics announced it had raised $20 million in Series A financing from Atlas Venture, Roche Ventures, ... «Genetic Engineering & Biotechnology News, 七月 15»
